Revlimid in Transfusion Dependent Patients

Clinical trial NCT01178814 · COMPLETED

Trial details

NCT number: NCT01178814
Sponsor: Columbia University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome

Start date: 2009-06-01
Primary completion: 2022-09-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.